Medical Tourism Market Research, 2032

The global medical tourism market size was valued at $97,311.04 million in 2022 and is projected to reach $273,722.42 million by 2032, registering a CAGR of 10.1% from 2023 to 2032. In terms of volume, the global medical tourism market accounted for 21,110.54 thousand patients in 2022, and is projected to reach 71,174.94 thousand patients by 2032, registering a CAGR of 11.8% from 2023 to 2032. Rapid advancements in medical technology and telemedicine have facilitated the globalization of healthcare services. Patients now research and connect with medical facilities and professionals worldwide, making it easier to access information about treatment options, costs, and quality of care in various medical tourism destinations.

Market Introduction and Definition

Medical tourism, also known as health tourism or medical travel, is a practice in which individuals travel across international borders to seek medical, dental, surgical, or healthcare services. This phenomenon encompasses a wide spectrum of treatments, from elective and cosmetic procedures to specialized medical interventions and complex surgeries. Medical tourism extends beyond the medical procedures themselves, including pre-operative and post-operative care, consultations, diagnostics, rehabilitation, and recovery.

Impact of Recession 2023 on Medical Tourism Market

The medical tourism market was moderately impacted by the economic recession, owing to economic uncertainties and reduced disposable income leading to a decline in demand for elective medical procedures, causing patients to delay or cancel travel for non-essential treatments. On the other hand, recessions drive cost-conscious individuals to seek more affordable healthcare options abroad, especially for procedures not covered by insurance.

Key Market Dynamics

One of the primary drivers of the medical tourism market is the potential for cost savings. Many individuals from high-cost healthcare countries, such as the U.S., Canada, and various European nations, seek medical treatment abroad where they access high-quality healthcare services at a fraction of the cost. This cost differential is a particularly significant driver for elective procedures, cosmetic surgeries, dental treatments, and fertility treatments. Patients often find that even with travel expenses factored in, the overall cost of treatment abroad is substantially lower than receiving the same care domestically.

In addition, access to high-quality healthcare is another crucial driver for medical tourism. Many countries, such as Singapore, Thailand, South Korea, and India, have invested heavily in building world-class medical facilities and acquiring cutting-edge medical technologies. This investment has resulted in the availability of advanced medical treatments, specialized procedures, and highly skilled medical professionals, which attract patients seeking top quality care. The reputation of these destinations for medical excellence is a significant factor in drawing international patients.

Further, in some countries with publicly funded healthcare systems, long waiting times for certain medical procedures be a significant issue. Patients facing extended waiting lists for surgeries or diagnostic tests opt to travel abroad for quicker access to medical services. Medical tourism destinations often offer shorter waiting times, allowing patients to undergo necessary treatments more promptly.

Medical tourism destinations frequently excel in providing specialized medical services that might not be readily available or easily accessible in patients' home countries. These include complex surgeries, organ transplants, advanced cancer treatments, fertility procedures, and innovative therapies. Patients with specific healthcare needs are drawn to destinations with expertise in their particular medical condition.

In addition, some countries actively promote medical tourism as a part of their economic development strategy. Governments offer incentives, tax breaks, and infrastructure support to attract international patients and healthcare investments. This government support significantly boosts the growth of the medical tourism industry in specific regions.

Further, with the proliferation of the internet and the ease of accessing information, individuals are becoming more aware of the possibilities offered by medical tourism. They research healthcare providers, read patient testimonials, and compare treatment options, enabling them to make informed decisions about seeking treatment abroad.

During a recession, the medical tourism market experiences a decline in demand for elective and non-essential medical procedures. Economic uncertainty often leads individuals to prioritize cost savings, causing them to delay cosmetic surgeries, dental treatments, and other non-urgent healthcare services typically associated with medical tourism. In addition, fluctuations in currency exchange rates affect the affordability of treatments in foreign destinations, potentially reducing the appeal of medical tourism. Travel restrictions and concerns about healthcare quality and safety further dampen international patient flows during economic downturns.

However, a recession leads to increased interest in medical tourism among cost-conscious individuals seeking to save on healthcare expenses. Countries renowned for providing high-quality care at lower costs see a surge in international patients looking for affordable treatments. In addition, medical tourism destinations and providers respond to heightened competition by improving service quality and offering attractive packages, ultimately enhancing the overall patient experience.

Market Segmentation

The medical tourism market is segmented into treatment type and region. By treatment type, the market is segregated into dental treatment, cosmetic treatment, cardiovascular treatment, orthopedic treatment, neurological treatment, cancer treatment, fertility treatment, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (India, China, Indonesia, Singapore, Malaysia, Thailand, South Korea, Taiwan and Rest of Asia-Pacific), and LAMEA (Brazil, Venezuela, Costa Rica, UAE, South Africa and Rest of LAMEA).

By Treatment Type

The cancer treatment segment accounted for largest share in 2022, owing to several factors. These include the increasing worldwide incidence of cancer, the escalating costs of cancer care in many countries, the demand for advanced and specialized treatment options, reduced waiting periods, the preference for comprehensive and holistic healthcare services, and the willingness of patients to travel in pursuit of potentially life-saving treatments. The urgency and gravity of cancer diagnoses, coupled with the pursuit of optimal treatment outcomes, compel patients to explore medical tourism options for cancer care.

[TREATMENTTYPEGRAPH]

However, the orthopedic treatment segment is expected to register the highest CAGR during the forecast period. This be attributed to various factors such as the growing global prevalence of orthopedic ailments, an aging population, the necessity for specialized procedures such as joint replacements and spinal surgeries, the substantial costs and extended waiting times for such treatments in many countries, the demand for expert orthopedic healthcare, and the presence of world-class orthopedic facilities in medical tourism destinations. Patients are increasingly seeking prompt and cost-efficient solutions for orthopedic conditions, propelling the expansion of this segment within the medical tourism market.

By Region

The medical tourism market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Region wise, Asia-Pacific accounted for largest share in 2022 and is anticipated to witness notable growth during the forecast period, owing to factors such as cost-effective healthcare solutions, strong healthcare infrastructure with advanced facilities and highly skilled medical professionals. In addition, the availability of specialized medical procedures, shorter waiting times, and government support for medical tourism contribute to the market growth in the region.

Asia-Pacific is well known for offering cost-effective healthcare solutions, making it an attractive destination for individuals seeking medical treatments. Compared to many Western countries, medical procedures in Asia-Pacific nations are often more affordable, which propels market growth.

Furthermore, the region boasts a robust healthcare infrastructure equipped with advanced medical facilities and a highly skilled workforce of medical professionals. This combination of modern technology and expertise instills confidence in patients seeking healthcare services in the Asia-Pacific region. They access state-of-the-art treatments and benefit from the proficiency of healthcare providers.

Moreover, a notable advantage in the Asia-Pacific region is the availability of specialized medical procedures. Many countries within the region have developed expertise in medical fields, such as cardiac surgeries and advanced cancer treatments. This specialization attracts patients with specific healthcare needs, further propelling the region's medical tourism market growth.

In addition, shorter waiting times for medical procedures are another significant driver. In contrast to countries with long waiting lists, Asia-Pacific destinations often offer quicker access to healthcare services. This is especially appealing to patients who are not able to wait for essential treatments.

Further, government support is yet another pivotal factor contributing to the region's burgeoning medical tourism industry. Some governments in Asia-Pacific actively promote medical tourism by investing in healthcare infrastructure, implementing favorable policies, and launching marketing campaigns to attract international patients. Such initiatives facilitate the growth of medical tourism.

Asia-Pacific is expected to grow at the highest CAGR during the forecast period. The market growth in this region is attributable to presence of medical technology companies in the region as well as growth in the purchasing power of populated countries, such as China and India. Furthermore, Asia-Pacific offers profitable opportunities for key players operating in the medical tourism market, thereby registering the fastest growth rate during the forecast period, owing to the rise in infrastructure of healthcare industries and surge in healthcare expenditure.

Competitive Landscape

Competitive analysis and profiles of the major players in the medical tourism market, such as Bumrungrad International Hospital, Asian Heart Institute, Clemenceau Medical Center, Bangkok Dusit Medical Services, Apollo Hospitals Group, KPJ Healthcare Berhad, Asklepios Kliniken GmbH & Co. KGaA, IHH Healthcare, Specialty Hospital and Anadolu Medical Center are provided in this report. Major players have adopted collaboration, product launch, agreement, clinical trial approval, acquisition, and product approval to expand their service portfolio.

Recent Key Strategies and Developments​​​​​​​

• In November 2021, Apollo Cancer Centre introduced a groundbreaking fast-forward breast cancer radiation therapy in the West Bengal area. The conventional treatment regimen for breast cancer typically spans a lengthy six to eight months, encompassing chemotherapy, radiation therapy, and other necessary interventions. However, with such cutting-edge technology, breast cancer radiation treatment now be administered in a mere one-week timeframe, dramatically reducing the previous 3 to 5-week duration.
• In June 2023, Bumrungrad invests in Thailand’s first campus in Phuket to build 150-bed boutique hospital and advanced diagnostic center. The new hospital will be built using Bumrungrad's strategy of providing personalized care and innovative medical technology to patients.
• In November 2022, Apollo Hospitals has expanded Vertigo and Balance Disorder Clinic in Hyderabad, pioneering the growth of vertigo treatment in India. Being one of the most underdiagnosed problems worldwide, this clinic is meant to bring a revolutionary change in the way vertigo is perceived and treated in the country.
• In April 2023, Samsung Electronics Co., Ltd. and KPJ Healthcare Berhad have entered into a collaboration aimed at advancing precision medicine and diagnostics in Malaysia.
• In July 2023, KPJ Healthcare Berhad, Malaysia’s largest private healthcare provider, has signed a Memorandum of Understanding (MoU) with Gentari Sdn Bhd, a leading clean energy solutions provider, to embark on a strategic collaboration that will drive decarbonization efforts in the healthcare sector and propel KPJ Healthcare toward sustainable growth.
• In 2023, IHH Healthcare is expanding its continuum of medical care services to East Malaysia by acquiring Timberland Medical Centre and build new 200-bed hospital in Kuching, Sarawak.

Key Benefits for Stakeholders

• This report entails a detailed quantitative analysis of the current medical tourism market trends from 2023 - 2032 to identify the prevailing opportunities.
• Medical tourism market size and estimations are based on comprehensive analysis of the key developments in the industry.
• In-depth analysis based on region assists to understand the regional medical tourism market and the strategic business planning.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global medical tourism market.

 Key Market Segments

• By Treatment Type
  • Dental Treatment
  • Cosmetic Treatment
  • Cardiovascular Treatment
  • Orthopedic Treatment
  • Neurological Treatment
  • Cancer Treatment
  • Fertility Treatment
  • Other Treatments
• By Key Market Players
  • Bumrungrad International Hospital
  • Asian Heart Institute
  • Clemenceau Medical Center
  • Bangkok Dusit Medical Services
  • Apollo Hospitals Group
  • KPJ Healthcare Berhad
  • Asklepios Kliniken GmbH & Co. KGaA
  • IHH Healthcare
  • Specialty Hospital
  • Anadolu Medical Center

 
Key Market Players

• FORTIS HEALTHCARE LIMITED
• APOLLO HOSPITALS ENTERPRISE LIMITED
• PRINCE COURT MEDICAL CENTRE
• UZ LEUVEN
• NTT Medical Center Tokyo
• ASIAN HEART INSTITUTE
• KPJ HEALTHCARE BERHAD
• ADITYA BIRLA MEMORIAL HOSPITAL
• WOORIDUL SPINE HOSPITAL
• SEOUL NATIONAL UNIVERSITY HOSPITAL.
• SAMITIVEJ PCL.
• BARBADOS FERTILITY CENTER

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis
3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Low cost of medical treatment in developing countries
3.4.1.2.Availability of advanced medical technologies
3.4.1.3.Increase in awareness about medical tourism

3.4.2.Restraints

3.4.2.1.Limited coverage and lengthy partial reimbursement by payers

3.4.3.Opportunities

3.4.3.1.Growing opportunities in emerging markets

3.5.Impact analysis of recession on the medical tourism market

CHAPTER 4:MEDICAL TOURISM MARKET, BY TREATMENT TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Dental treatment

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region

4.2.2.1.Market size and forecast, by North America
4.2.2.2.Market size and forecast, by Europe
4.2.2.3.Market size and forecast, by Asia-Pacific
4.2.2.4.Market size and forecast, by LAMEA

4.3.Cosmetic treatment

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region

4.3.2.1.Market size and forecast, by North America
4.3.2.2.Market size and forecast, by Europe
4.3.2.3.Market size and forecast, by Asia-Pacific
4.3.2.4.Market size and forecast, by LAMEA

4.4.Cardiovascular treatment

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region

4.4.2.1.Market size and forecast, by North America
4.4.2.2.Market size and forecast, by Europe
4.4.2.3.Market size and forecast, by Asia-Pacific
4.4.2.4.Market size and forecast, by LAMEA

4.5.Orthopedic treatment

4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region

4.5.2.1.Market size and forecast, by North America
4.5.2.2.Market size and forecast, by Europe
4.5.2.3.Market size and forecast, by Asia-Pacific
4.5.2.4.Market size and forecast, by LAMEA

4.6.Neurological treatment

4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast, by region

4.6.2.1.Market size and forecast, by North America
4.6.2.2.Market size and forecast, by Europe
4.6.2.3.Market size and forecast, by Asia-Pacific
4.6.2.4.Market size and forecast, by LAMEA

4.7.Cancer treatment

4.7.1.Key market trends, growth factors, and opportunities
4.7.2.Market size and forecast, by region

4.7.2.1.Market size and forecast, by North America
4.7.2.2.Market size and forecast, by Europe
4.7.2.3.Market size and forecast, by Asia-Pacific
4.7.2.4.Market size and forecast, by LAMEA

4.8.Fertility treatment

4.8.1.Key market trends, growth factors, and opportunities
4.8.2.Market size and forecast, by region

4.8.2.1.Market size and forecast, by North America
4.8.2.2.Market size and forecast, by Europe
4.8.2.3.Market size and forecast, by Asia-Pacific
4.8.2.4.Market size and forecast, by LAMEA

4.9.Other treatments

4.9.1.Key market trends, growth factors, and opportunities
4.9.2.Market size and forecast, by region

4.9.2.1.Market size and forecast, by North America
4.9.2.2.Market size and forecast, by Europe
4.9.2.3.Market size and forecast, by Asia-Pacific
4.9.2.4.Market size and forecast, by LAMEA

CHAPTER 5:MEDICAL TOURISM MARKET, BY REGION

5.1.Overview

5.1.1.Market size and forecast

5.2.North America

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by country
5.2.3.Market size and forecast, by treatment type

5.2.3.1.U.S. market size and forecast

5.2.3.1.1.Market size and forecast, by treatment type

5.2.3.2.Canada market size and forecast

5.2.3.2.1.Market size and forecast, by treatment type

5.2.3.3.Mexico market size and forecast

5.2.3.3.1.Market size and forecast, by treatment type

5.3.Europe

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by country
5.3.3.Market size and forecast, by treatment type

5.3.3.1.Germany market size and forecast

5.3.3.1.1.Market size and forecast, by treatment type

5.3.3.2.France market size and forecast

5.3.3.2.1.Market size and forecast, by treatment type

5.3.3.3.UK market size and forecast

5.3.3.3.1.Market size and forecast, by treatment type

5.3.3.4.Italy market size and forecast

5.3.3.4.1.Market size and forecast, by treatment type

5.3.3.5.Spain market size and forecast

5.3.3.5.1.Market size and forecast, by treatment type

5.3.3.6.Rest of Europe market size and forecast

5.3.3.6.1.Market size and forecast, by treatment type

5.4.Asia-Pacific

5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by country
5.4.3.Market size and forecast, by treatment type

5.4.3.1.India market size and forecast

5.4.3.1.1.Market size and forecast, by treatment type

5.4.3.2.China market size and forecast

5.4.3.2.1.Market size and forecast, by treatment type

5.4.3.3.Indonesia market size and forecast

5.4.3.3.1.Market size and forecast, by treatment type

5.4.3.4.Singapore market size and forecast

5.4.3.4.1.Market size and forecast, by treatment type

5.4.3.5.Malaysia market size and forecast

5.4.3.5.1.Market size and forecast, by treatment type

5.4.3.6.Thailand market size and forecast

5.4.3.6.1.Market size and forecast, by treatment type

5.4.3.7.South Korea market size and forecast

5.4.3.7.1.Market size and forecast, by treatment type

5.4.3.8.Taiwan market size and forecast

5.4.3.8.1.Market size and forecast, by treatment type

5.4.3.9.Rest of Asia-Pacific market size and forecast

5.4.3.9.1.Market size and forecast, by treatment type

5.5.LAMEA

5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast, by country
5.5.3.Market size and forecast, by treatment type

5.5.3.1.Brazil market size and forecast

5.5.3.1.1.Market size and forecast, by treatment type

5.5.3.2.Venezuela market size and forecast

5.5.3.2.1.Market size and forecast, by treatment type

5.5.3.3.Costa Rica market size and forecast

5.5.3.3.1.Market size and forecast, by treatment type

5.5.3.4.UAE market size and forecast

5.5.3.4.1.Market size and forecast, by treatment type

5.5.3.5.South Africa market size and forecast

5.5.3.5.1.Market size and forecast, by treatment type

5.5.3.6.Rest of LAMEA market size and forecast

5.5.3.6.1.Market size and forecast, by treatment type

CHAPTER 6:COMPETITIVE LANDSCAPE

6.1.Introduction
6.2.Top winning strategies

6.2.1.Top winning strategies, by year, 2020-2023*
6.2.2.Top winning strategies, by development, 2020-2023*
6.2.3.Top winning strategies, by company, 2020-2023*

6.3.Product mapping of top 10 player
6.4.Competitive dashboard
6.5.Competitive heatmap
6.6.Top player positioning

CHAPTER 7:COMPANY PROFILE

7.1.BUMRUNGRAD INTERNATIONAL HOSPITAL

7.1.1.Company overview (business description)
7.1.2.Operating business segment
7.1.3.Business performance
7.1.4.Product portfolio
7.1.5.Key strategic moves and developments

7.2.CLEMENCEAU MEDICAL CENTER

7.2.1.Company overview (business description)
7.2.2.Operating business segment
7.2.3.Product portfolio

7.3.ASIAN HEART INSTITUTE

7.3.1.Company overview (business description)
7.3.2.Operating business segment
7.3.3.Product portfolio

7.4.BANGKOK DUSIT MEDICAL SERVICES

7.4.1.Company overview (business description)
7.4.2.Operating business segments
7.4.3.Business performance
7.4.4.Product portfolio

7.5.APOLLO HOSPITALS GROUP

7.5.1.Company overview (business description)
7.5.2.Operating business segments
7.5.3.Business performance
7.5.4.Product portfolio
7.5.5.Key strategic moves and developments

7.6.KPJ HEALTHCARE BERHAD

7.6.1.Company overview (business description)
7.6.2.Operating business segments
7.6.3.Business performance
7.6.4.Product portfolio
7.6.5.Key strategic moves and developments

7.7.ASKLEPIOS KLINIKEN GMBH and CO. KGAA

7.7.1.Company overview (business description)
7.7.2.Operating business segments
7.7.3.Business performance
7.7.4.Product portfolio

7.8.IHH HEALTHCARE

7.8.1.Company overview (business description)
7.8.2.Operating business segments
7.8.3.Business performance
7.8.4.Product portfolio
7.8.5.Key strategic moves and developments

7.9.SPECIALTY HOSPITAL

7.9.1.Company overview (business description)
7.9.2.Operating business segment
7.9.3.Product portfolio

7.10.ANADOLU MEDICAL CENTER

7.10.1.Company overview (business description)
7.10.2.Operating business segments
7.10.3.Product portfolio

LIST OF TABLES

TABLE 02.GLOBAL MEDICAL TOURISM MARKET, BY TREATMENT TYPE, 2022–2032 ($MILLION)
TABLE 03.GLOBAL MEDICAL TOURISM MARKET, BY TREATMENT TYPE, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 04.MEDICAL TOURISM MARKET FOR DENTAL TREATMENT, BY REGION, 2022–2032 ($MILLION)
TABLE 05.MEDICAL TOURISM MARKET FOR DENTAL TREATMENT, BY REGION, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 06.NORTH AMERICA MEDICAL TOURISM MARKET FOR DENTAL TREATMENT, BYCOUNTRY, 2022–2032 ($MILLION)
TABLE 07.NORTH AMERICA MEDICAL TOURISM MARKET FOR DENTAL TREATMENT, BYCOUNTRY, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 08.EUROPE MEDICAL TOURISM MARKET FOR DENTAL TREATMENT, BY COUNTRY, 2022–2032 ($MILLION)
TABLE 09.EUROPE MEDICAL TOURISM MARKET FOR DENTAL TREATMENT, BY COUNTRY, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 10.ASIA-PACIFIC MEDICAL TOURISM MARKET FOR DENTAL TREATMENT, BY COUNTRY, 2022–2032 ($MILLION)
TABLE 11.ASIA-PACIFIC MEDICAL TOURISM MARKET FOR DENTAL TREATMENT, BY COUNTRY, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 12.LAMEA MEDICAL TOURISM MARKET FOR DENTAL TREATMENT, BY COUNTRY, 2022–2032 ($MILLION)
TABLE 13.MEDICAL TOURISM MARKET FOR DENTAL TREATMENT, BY LAMEA, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 14.MEDICAL TOURISM MARKET FOR COSMETIC TREATMENT, BY REGION, 2022–2032 ($MILLION)
TABLE 15.MEDICAL TOURISM MARKET FOR COSMETIC TREATMENT, BY REGION, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 16.MEDICAL TOURISM MARKET FOR COSMETIC TREATMENT, BY NORTH AMERICA, 2022–2032 ($MILLION)
TABLE 17.MEDICAL TOURISM MARKET FOR COSMETIC TREATMENT, BY NORTH AMERICA, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 18.MEDICAL TOURISM MARKET FOR COSMETIC TREATMENT, BY EUROPE, 2022–2032 ($MILLION)
TABLE 19.MEDICAL TOURISM MARKET FOR COSMETIC TREATMENT, BY EUROPE, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 20.MEDICAL TOURISM MARKET FOR COSMETIC TREATMENT, BY ASIA-PACIFIC, 2022–2032 ($MILLION)
TABLE 21.MEDICAL TOURISM MARKET FOR COSMETIC TREATMENT, BY ASIA-PACIFIC, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 22.MEDICAL TOURISM MARKET FOR COSMETIC TREATMENT, BY LAMEA, 2022–2032 ($MILLION)
TABLE 23.MEDICAL TOURISM MARKET FOR COSMETIC TREATMENT, BY LAMEA, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 24.MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY REGION, 2022–2032 ($MILLION)
TABLE 25.MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY REGION, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 26.MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY NORTH AMERICA, 2022–2032 ($MILLION)
TABLE 27.MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY NORTH AMERICA, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 28.MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY EUROPE, 2022–2032 ($MILLION)
TABLE 29.MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY EUROPE, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 30.MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY ASIA-PACIFIC, 2022–2032 ($MILLION)
TABLE 31.MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY ASIA-PACIFIC, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 32.MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY LAMEA, 2022–2032 ($MILLION)
TABLE 33.MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY LAMEA, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 34.MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY REGION, 2022–2032 ($MILLION)
TABLE 35.MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY REGION, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 36.MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY NORTH AMERICA, ($MILLION)
TABLE 37.MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY NORTH AMERICA, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 38.MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY EUROPE, 2022–2032 ($MILLION)
TABLE 39.MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY EUROPE, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 40.MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY ASIA-PACIFIC, 2022–2032 ($MILLION)
TABLE 41.MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY ASIA-PACIFIC, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 42.MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY LAMEA, 2022–2032 ($MILLION)
TABLE 43.MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY LAMEA, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 44.MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY REGION, 2022–2032 ($MILLION)
TABLE 45.MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY REGION, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 46.MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY NORTH AMERICA, 2022–2032 ($MILLION)
TABLE 47.MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY NORTH AMERICA, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 48.MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY EUROPE, 2022–2032 ($MILLION)
TABLE 49.MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY EUROPE, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 50.MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY ASIA-PACIFIC, 2022–2032 ($MILLION)
TABLE 51.MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY ASIA-PACIFIC, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 52.MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY LAMEA, 2022–2032 ($MILLION)
TABLE 53.MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY LAMEA, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 54.MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY REGION, 2022–2032 ($MILLION)
TABLE 55.MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY REGION, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 56.MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY NORTH AMERICA, 2022–2032 ($MILLION)
TABLE 57.MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY NORTH AMERICA, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 58.MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY EUROPE, 2022–2032 ($MILLION)
TABLE 59.MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY EUROPE, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 60.MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY ASIA-PACIFIC, 2022–2032 ($MILLION)
TABLE 61.MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY ASIA-PACIFIC, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 62.MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY LAMEA, 2022–2032 ($MILLION)
TABLE 63.MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY LAMEA, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 64.MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY REGION, 2022–2032 ($MILLION)
TABLE 65.MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY REGION, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 66.MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY NORTH AMERICA, 2022–2032 ($MILLION)
TABLE 67.MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY NORTH AMERICA, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 68.MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY EUROPE, 2022–2032 ($MILLION)
TABLE 69.MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY EUROPE, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 70.MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY ASIA-PACIFIC, 2022–2032 ($MILLION)
TABLE 71.MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY ASIA-PACIFIC, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 72.MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY LAMEA, 2022–2032 ($MILLION)
TABLE 73.MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY LAMEA, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 74.MEDICAL TOURISM MARKET FOR OTHER TREATMENTS, BY REGION, 2022–2032 ($MILLION)
TABLE 75.MEDICAL TOURISM MARKET FOR OTHER TREATMENTS, BY REGION, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 76.MEDICAL TOURISM MARKET FOR OTHER TREATMENTS, BY NORTH AMERICA, 2019–2027 ($MILLION)
TABLE 77.MEDICAL TOURISM MARKET FOR OTHER TREATMENTS, BY NORTH AMERICA, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 78.MEDICAL TOURISM MARKET FOR OTHER TREATMENTS, BY EUROPE, 2022–2032 ($MILLION)
TABLE 79.MEDICAL TOURISM MARKET FOR OTHER TREATMENTS, BY EUROPE, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 80.MEDICAL TOURISM MARKET FOR OTHER TREATMENTS, BY ASIA-PACIFIC, 2022–2032 ($MILLION)
TABLE 81.MEDICAL TOURISM MARKET FOR OTHER TREATMENTS, BY ASIA-PACIFIC, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 82.MEDICAL TOURISM MARKET FOR OTHER TREATMENTS, BY LAMEA, 2022–2032 ($MILLION)
TABLE 83.MEDICAL TOURISM MARKET FOR OTHER TREATMENTS, BY LAMEA, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 84.MEDICAL TOURISM MARKET REVENUE, BY REGION, 2022–2032 ($MILLION)
TABLE 85.MEDICAL TOURISM MARKET REVENUE, BY REGION, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 86.NORTH AMERICA MEDICAL TOURISM MARKET, BY COUNTRY, 2022–2032 ($MILLION)
TABLE 87.NORTH AMERICA MEDICAL TOURISM MARKET, BY COUNTRY, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 88.NORTH AMERICA MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 ($MILLION)
TABLE 89.NORTH AMERICA MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 90.U.S. TOURISM MARKET, BY TREATMENT, 2022–2032 ($MILLION)
TABLE 91.U.S. MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 92.CANADA. TOURISM MARKET, BY TREATMENT, 2022–2032 ($MILLION)
TABLE 93.CANADA MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 94.MEXICO. TOURISM MARKET, BY TREATMENT, 2022–2032 ($MILLION)
TABLE 95.MEXICO MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 96.EUROPE MEDICAL TOURISM MARKET, BY COUNTRY, 2022–2032 ($MILLION)
TABLE 97.EUROPE MEDICAL TOURISM MARKET, BY COUNTRY, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 98.EUROPE MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 ($MILLION)
TABLE 99.EUROPE MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 100.GERMANY MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 ($MILLION)
TABLE 101.GERMANY MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 102.FRANCE TOURISM MARKET, BY TREATMENT, 2022–2032 ($MILLION)
TABLE 103.FRANCE MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 104.UK MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 ($MILLION)
TABLE 105.UK MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 106.ITALY MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 ($MILLION)
TABLE 107.ITALY MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 108.SPAIN TOURISM MARKET, BY TREATMENT, 2022–2032 ($MILLION)
TABLE 109.SPAIN MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 110.REST OF EUROPE TOURISM MARKET, BY TREATMENT, 2022–2032 ($MILLION)
TABLE 111.REST OF EUROPE MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 112.ASIA-PACIFIC MEDICAL TOURISM MARKET, BY COUNTRY, 2022–2032 ($MILLION)
TABLE 113.ASIA-PACIFIC MEDICAL TOURISM MARKET, BY COUNTRY, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 114.ASIA-PACIFIC MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 ($MILLION)
TABLE 115.ASIA-PACIFIC MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 116.INDIA TOURISM MARKET, BY TREATMENT, 2022–2032 ($MILLION)
TABLE 117.INDIA MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 118.CHINA TOURISM MARKET, BY TREATMENT, 2022–2032 ($MILLION)
TABLE 119.CHINA MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 120.INDONESIA TOURISM MARKET, BY TREATMENT, 2022–2032 ($MILLION)
TABLE 121.INDONESIA MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 122.SINGAPORE TOURISM MARKET, BY TREATMENT, 2022–2032 ($MILLION)
TABLE 123.SINGAPORE MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 124.MALAYSIA TOURISM MARKET, BY TREATMENT, 2022–2032 ($MILLION)
TABLE 125.MALAYSIA MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 126.THAILAND TOURISM MARKET, BY TREATMENT, 2022–2032 ($MILLION)
TABLE 127.THAILAND MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 128.SOUTH KOREA TOURISM MARKET, BY TREATMENT, 2022–2032 ($MILLION)
TABLE 129.SOUTH KOREA MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 130.TAIWAN TOURISM MARKET, BY TREATMENT, 2022–2032 ($MILLION)
TABLE 131.TAIWAN MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 132.REST OF ASIA-PACIFIC TOURISM MARKET, BY TREATMENT, 2022–2032 ($MILLION)
TABLE 133.REST OF ASIA-PACIFIC MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 134.LAMEA MEDICAL TOURISM MARKET, BY COUNTRY, 2022–2032 ($MILLION)
TABLE 135.LAMEA MEDICAL TOURISM MARKET, BY COUNTRY, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 136.LAMEA MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 ($MILLION)
TABLE 137.LAMEA MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 138.BRAZIL TOURISM MARKET, BY TREATMENT, 2022–2032 ($MILLION)
TABLE 139.BRAZIL MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 140.VENEZUELA TOURISM MARKET, BY TREATMENT, 2022–2032 ($MILLION)
TABLE 141.VENEZUELA MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 142.COSTA RICA TOURISM MARKET, BY TREATMENT, 2022–2032 ($MILLION)
TABLE 143.COSTA RICA MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 144.UAE TOURISM MARKET, BY TREATMENT, 2022–2032 ($MILLION)
TABLE 145.UAE MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 146.SOUTH AFRICA TOURISM MARKET, BY TREATMENT, 2022–2032 ($MILLION)
TABLE 147.SOUTH AFRICA MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 148.REST OF LAMEA TOURISM MARKET, BY TREATMENT, 2022–2032 ($MILLION)
TABLE 149.REST OF LAMEA MEDICAL TOURISM MARKET, BY TREATMENT, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)

LIST OF FIGURES

FIGURE 01.GLOBAL MEDICAL TOURISM MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.HIGH BARGANING POWER OF BUYERS
FIGURE 04.MODERATE BARGANING POWER OF SUPPLIERS
FIGURE 05.MODERATE THREAT OF SUBSTITUTION
FIGURE 06.MODERATE THREAT OF NEW ENTRANTS
FIGURE 07.MODERATE COMPETITIVE RIVALRY
FIGURE 08.U.S. MEDICAL TOURISM MARKET, 2022–2032 ($MILLION)
FIGURE 09.U.S. MEDICAL TOURISM MARKET, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 10.CANADA MEDICAL TOURISM MARKET, 2022–2032 ($MILLION)
FIGURE 11.CANADA MEDICAL TOURISM MARKET, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 12.MEXICO MEDICAL TOURISM MARKET, 2022–2032 ($MILLION)
FIGURE 13.MEXICO MEDICAL TOURISM MARKET, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 14.GERMANY MEDICAL TOURISM MARKET, 2022–2032 ($MILLION)
FIGURE 15.GERMANY MEDICAL TOURISM MARKET, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 16.FRANCE MEDICAL TOURISM MARKET, 2022–2032 ($MILLION)
FIGURE 17.FRANCE MEDICAL TOURISM MARKET, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 18.UK MEDICAL TOURISM MARKET, 2022–2032 ($MILLION)
FIGURE 19.UK MEDICAL TOURISM MARKET, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 20.ITALY MEDICAL TOURISM MARKET, 2022–2032 ($MILLION)
FIGURE 21.ITALY MEDICAL TOURISM MARKET, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 22.SPAIN MEDICAL TOURISM MARKET, 2022–2032 ($MILLION)
FIGURE 23.SPAIN MEDICAL TOURISM MARKET, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 24.REST OF EUROPE MEDICAL TOURISM MARKET, 2022–2032 ($MILLION)
FIGURE 25.REST OF EUROPE MEDICAL TOURISM MARKET, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 26.INDIA MEDICAL TOURISM MARKET, 2022–2032 ($MILLION)
FIGURE 27.INDIA MEDICAL TOURISM MARKET, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 28.CHINA MEDICAL TOURISM MARKET, 2022–2032 ($MILLION)
FIGURE 29.CHINA MEDICAL TOURISM MARKET, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 30.INDONESIA MEDICAL TOURISM MARKET, 2022–2032 ($MILLION)
FIGURE 31.INDONESIA MEDICAL TOURISM MARKET, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 32.SINGAPORE MEDICAL TOURISM MARKET, 2022–2032 ($MILLION)
FIGURE 33.SINGAPORE MEDICAL TOURISM MARKET, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 34.MALAYSIA MEDICAL TOURISM MARKET, 2022–2032 ($MILLION)
FIGURE 35.MALAYSIA MEDICAL TOURISM MARKET, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 36.THAILAND MEDICAL TOURISM MARKET, 2022–2032 ($MILLION)
FIGURE 37.THAILAND MEDICAL TOURISM MARKET, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 38.SOUTH KOREA MEDICAL TOURISM MARKET, 2022–2032 ($MILLION)
FIGURE 39.SOUTH KOREA MEDICAL TOURISM MARKET, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 40.TAIWAN MEDICAL TOURISM MARKET, 2022–2032 ($MILLION)
FIGURE 41.TAIWAN MEDICAL TOURISM MARKET, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 42.REST OF EUROPE MEDICAL TOURISM MARKET, 2022–2032 ($MILLION)
FIGURE 43.REST OF EUROPE MEDICAL TOURISM MARKET, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 44.BRAZIL MEDICAL TOURISM MARKET, 2022–2032 ($MILLION)
FIGURE 45.BRAZIL MEDICAL TOURISM MARKET, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 46.VENEZUELA MEDICAL TOURISM MARKET, 2022–2032 ($MILLION)
FIGURE 47.VENEZUELA MEDICAL TOURISM MARKET, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 48.COSTA RICA MEDICAL TOURISM MARKET, 2022–2032 ($MILLION)
FIGURE 49.COSTA RICA MEDICAL TOURISM MARKET, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 50.UAE MEDICAL TOURISM MARKET, 2022–2032 ($MILLION)
FIGURE 51.UAE MEDICAL TOURISM MARKET, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 52.SOUTH AFRICA MEDICAL TOURISM MARKET, 2022–2032 ($MILLION)
FIGURE 53.SOUTH AFRICA MEDICAL TOURISM MARKET, 2022–2032  (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 54.REST OF LAMEA MEDICAL TOURISM MARKET, 2022–2032 ($MILLION)
FIGURE 55.REST OF LAMEA MEDICAL TOURISM MARKET, 2022–2032 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 56.TOP WINNING STRATEGIES, BY YEAR, 2020-2023*
FIGURE 57.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2023*
FIGURE 58.TOP WINNING STRATEGIES, BY COMPANY, 2020-2023*
FIGURE 59.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 60.COMPETITIVE DASHBOARD
FIGURE 61.COMPETITIVE HEATMAP: MEDICAL TOURISM MARKET
FIGURE 62.TOP PLAYER POSITIONING, 2022